Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2001 2
2002 2
2003 3
2004 2
2005 3
2006 7
2007 5
2008 5
2009 3
2010 4
2011 8
2012 5
2013 6
2014 10
2015 7
2016 5
2017 14
2018 13
2019 10
2020 11
2021 14
2022 6
2023 11
2024 14
2025 16
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
Botanicals and Their Bioactive Phytochemicals for Women's Health.
Dietz BM, Hajirahimkhan A, Dunlap TL, Bolton JL. Dietz BM, et al. Pharmacol Rev. 2016 Oct;68(4):1026-1073. doi: 10.1124/pr.115.010843. Pharmacol Rev. 2016. PMID: 27677719 Free PMC article. Review.
Some examples include Vitex agnus-castus (chasteberry), Angelica sinensis (dong quai), Viburnum opulus/prunifolium (cramp bark and black haw), and Zingiber officinale (ginger). ...Several of these botanicals could have additional breast cancer preventive effe …
Some examples include Vitex agnus-castus (chasteberry), Angelica sinensis (dong quai), Viburnum opulus/prunifolium (cramp bark …
Angelica sinensis polysaccharide combined with cisplatin reverses cisplatin resistance of ovarian cancer by inducing ferroptosis via regulating GPX4.
Guo W, Wang W, Lei F, Zheng R, Zhao X, Gu Y, Yang M, Tong Y, Wang Y. Guo W, et al. Biomed Pharmacother. 2024 Jun;175:116680. doi: 10.1016/j.biopha.2024.116680. Epub 2024 May 4. Biomed Pharmacother. 2024. PMID: 38703506 Free article.
Angelica sinensis (Oliv.) Diels has been used for centuries in China to treat gynecological ailments. Numerous studies indicate that Angelica sinensis polysaccharide (ASP), an extract from Angelica sinensis, can inhibit various forms of …
Angelica sinensis (Oliv.) Diels has been used for centuries in China to treat gynecological ailments. Numerous studies indicat …
Efficacy and mechanisms of Angelica sinensis in treating endometrial cancer: an integrated study.
Li Z, Jia C, Zhou Y, Wang Q. Li Z, et al. Discov Oncol. 2025 May 24;16(1):904. doi: 10.1007/s12672-025-02619-8. Discov Oncol. 2025. PMID: 40411686 Free PMC article.
In this study, we systematically explored the effects and mechanism of action of Angelica sinensis (AS) in endometrial cancer (EC) using network pharmacology and molecular docking. ...In network pharmacology, ingredients of Angelica sinensis wer …
In this study, we systematically explored the effects and mechanism of action of Angelica sinensis (AS) in endometrial canc …
Tumorigenic risk of Angelica sinensis on ER-positive breast cancer growth through ER-induced stemness in vitro and in vivo.
Zhu H, You J, Wen Y, Jia L, Gao F, Ganesan K, Chen J. Zhu H, et al. J Ethnopharmacol. 2021 Nov 15;280:114415. doi: 10.1016/j.jep.2021.114415. Epub 2021 Jul 13. J Ethnopharmacol. 2021. PMID: 34271113
ETHNOPHARMACOLOGICAL RELEVANCE: The root of Angelica sinensis is widely used in traditional Chinese Medicine for relieving gynecological discomforts among the women population. However, its hormone-like effects have raised great attention on whether it is appropriat …
ETHNOPHARMACOLOGICAL RELEVANCE: The root of Angelica sinensis is widely used in traditional Chinese Medicine for relieving gyn …
Angelica sinensis polysaccharide suppresses the Wnt/beta-catenin-mediated malignant biological behaviors of breast cancer cells via the miR-3187-3p/PCDH10 axis.
Cai Y, Wang Y, Su W, Zhou X, Lu C. Cai Y, et al. Biochem Pharmacol. 2024 Jul;225:116295. doi: 10.1016/j.bcp.2024.116295. Epub 2024 May 16. Biochem Pharmacol. 2024. PMID: 38762145
Breast cancer (BC) is one of the most common malignant tumors in women. Angelica sinensis polysaccharide (ASP) is one of the main components extracted from the traditional Chinese medicine Angelica sinensis. Research has shown that ASP affects t …
Breast cancer (BC) is one of the most common malignant tumors in women. Angelica sinensis polysaccharide (ASP) is one o …
Supercritical fluid extract of Angelica sinensis promotes the anti-colorectal cancer effect of oxaliplatin.
Hao D, Liu J, Guo Z, Chen J, Li T, Li X, Mei K, Wang L, Wang X, Wu Q. Hao D, et al. Front Pharmacol. 2022 Nov 4;13:1007623. doi: 10.3389/fphar.2022.1007623. eCollection 2022. Front Pharmacol. 2022. PMID: 36408222 Free PMC article.
Therefore, it is necessary to find new drug candidates that can synergize with OXA and thereby lower the OXA dose while still maintaining its efficacy. Angelica sinensis is a common drug in traditional Chinese medicine and has demonstrated a significant anti-CRC eff …
Therefore, it is necessary to find new drug candidates that can synergize with OXA and thereby lower the OXA dose while still maintaining it …
Effect of Angelica sinensis Root Extract on Cancer Prevention in Different Stages of an AOM/DSS Mouse Model.
Zhao B, Kang Q, Peng Y, Xie Y, Chen C, Li B, Wu Q. Zhao B, et al. Int J Mol Sci. 2017 Aug 11;18(8):1750. doi: 10.3390/ijms18081750. Int J Mol Sci. 2017. PMID: 28800083 Free PMC article.
Angelica sinensis root (ASR) extract was obtained to investigate its effects on colorectal carcinogenesis in different stages of an Azoxymethane/Dextran sodium sulphate (AOM/DSS) model. In this study, we showed that ASR extract administration in the initial stage of …
Angelica sinensis root (ASR) extract was obtained to investigate its effects on colorectal carcinogenesis in different stages …
A population-based case-control study on the association of Angelica sinensis exposure with risk of breast cancer.
Chen JY, Wang YH, Hidajah AC, Li CY. Chen JY, et al. J Tradit Complement Med. 2019 Oct 23;10(5):454-459. doi: 10.1016/j.jtcme.2019.10.003. eCollection 2020 Sep. J Tradit Complement Med. 2019. PMID: 32953561 Free PMC article.
We also noted a stronger association with breast cancer with initial use of Angelica sinensis at a longer time before breast cancer diagnosis, and found that the seemingly protective effect of Angelica sinensis was more obvious among wome …
We also noted a stronger association with breast cancer with initial use of Angelica sinensis at a longer time before b …
Angelica sinensis polysaccharides promotes apoptosis in human breast cancer cells via CREB-regulated caspase-3 activation.
Zhou WJ, Wang S, Hu Z, Zhou ZY, Song CJ. Zhou WJ, et al. Biochem Biophys Res Commun. 2015 Nov 20;467(3):562-9. doi: 10.1016/j.bbrc.2015.09.145. Epub 2015 Sep 30. Biochem Biophys Res Commun. 2015. PMID: 26431878
Angelica sinensis polysaccharide (ASP) is purified from the fresh roots of Angelica sinensis (AS). ...In this study, we show that angelica sinensis polysaccharide induced apoptosis in breast cancer cells of T47D over-expressing the …
Angelica sinensis polysaccharide (ASP) is purified from the fresh roots of Angelica sinensis (AS). ...In this st …
Angelica Sinensis Polysaccharide-Based Nanoparticles for Liver-Targeted Delivery of Oridonin.
Sun H, Nai J, Deng B, Zheng Z, Chen X, Zhang C, Sheng H, Zhu L. Sun H, et al. Molecules. 2024 Feb 5;29(3):731. doi: 10.3390/molecules29030731. Molecules. 2024. PMID: 38338476 Free PMC article.
The present work aimed to study the feasibility of Angelica sinensis polysaccharide (ASP) as an instinctive liver targeting drug delivery carrier for oridonin (ORI) in the treatment of hepatocellular carcinoma (HCC). ...
The present work aimed to study the feasibility of Angelica sinensis polysaccharide (ASP) as an instinctive liver targeting dr …
175 results